Prevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting study
Objectives: Tuberculosis has an important burden of disease in developing countries. The aim of this study was to estimate the prevalence of latent tuberculosis infection (LTBI) in a cohort of patients with rheumatoid arthritis (RA) in a specialized center of excellence. Method: We conducted a retro...
- Autores:
-
Santos-Moreno, P
Alvis-Zakzuk, NJ
Carrasquilla, M
Villarreal, L
Alvis Guzman, N
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2018
- Institución:
- Corporación Universidad de la Costa
- Repositorio:
- REDICUC - Repositorio CUC
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cuc.edu.co:11323/4707
- Acceso en línea:
- https://hdl.handle.net/11323/4707
https://repositorio.cuc.edu.co/
- Palabra clave:
- Tuberculosis
Países en desarrollo
Prevalencia de la infección tuberculosa latente
Artritis reumatoide
Tuberculosis
Developing countries
Prevalence of latent tuberculosis infection
Rheumatoid arthritis
- Rights
- openAccess
- License
- Attribution-NonCommercial-ShareAlike 4.0 International
id |
RCUC2_bd5e3ec6891333c4d3b50bd592f6bb8e |
---|---|
oai_identifier_str |
oai:repositorio.cuc.edu.co:11323/4707 |
network_acronym_str |
RCUC2 |
network_name_str |
REDICUC - Repositorio CUC |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Prevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting study |
dc.title.translated.spa.fl_str_mv |
Prevalencia de la infección tuberculosa latente en pacientes con artritis reumatoide en Colombia: un estudio único. |
title |
Prevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting study |
spellingShingle |
Prevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting study Tuberculosis Países en desarrollo Prevalencia de la infección tuberculosa latente Artritis reumatoide Tuberculosis Developing countries Prevalence of latent tuberculosis infection Rheumatoid arthritis |
title_short |
Prevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting study |
title_full |
Prevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting study |
title_fullStr |
Prevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting study |
title_full_unstemmed |
Prevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting study |
title_sort |
Prevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting study |
dc.creator.fl_str_mv |
Santos-Moreno, P Alvis-Zakzuk, NJ Carrasquilla, M Villarreal, L Alvis Guzman, N |
dc.contributor.author.spa.fl_str_mv |
Santos-Moreno, P Alvis-Zakzuk, NJ Carrasquilla, M Villarreal, L Alvis Guzman, N |
dc.subject.spa.fl_str_mv |
Tuberculosis Países en desarrollo Prevalencia de la infección tuberculosa latente Artritis reumatoide Tuberculosis Developing countries Prevalence of latent tuberculosis infection Rheumatoid arthritis |
topic |
Tuberculosis Países en desarrollo Prevalencia de la infección tuberculosa latente Artritis reumatoide Tuberculosis Developing countries Prevalence of latent tuberculosis infection Rheumatoid arthritis |
description |
Objectives: Tuberculosis has an important burden of disease in developing countries. The aim of this study was to estimate the prevalence of latent tuberculosis infection (LTBI) in a cohort of patients with rheumatoid arthritis (RA) in a specialized center of excellence. Method: We conducted a retrospective study to explore the prevalence of LTBI in patients with RA in a single setting located in Bogota, Colombia. Under a Treat to Target model we followed patients diagnosed with RA who received biological and conventional therapy treated in 2017. Patients were tested using tuberculin skin test (TST). Thresholds of this test were defined according to CDC recommendations. We stratified the analysis by sex, type of treatment (conventional and biological therapy) and negative and positive LTBI. Means and standard deviations were reported for continuous variables and categorical variables were presented as percentages. Results: We included 329 patients diagnosed with AR who were tested for LTBI, 60,2% were women. Mean age was 67.1 years (standard deviation 10.4). According to the therapy, 77.2% were treated with biological and 22.8% with conventional therapy. As far as diseases were concerned including RA, some comorbidities were assessed at the beginning of the follow-up, showing that 26.4% (87/329) had hypertension, 6.1% (20/329) diabetes mellitus and 6,4% (21/329) Sjogren syndrome. As main result, the prevalence of LTBI in patients was 8.2% (27/329) (295 patients had a negative TST, 12 had a TST from 10mm to 15, and 15 patients had a TST >15mm). Conclusions: This study is one of the first approach in Colombia to estimate the prevalence of latent tuberculosis infection. Our estimation of LTBI prevalence was similar to the findings in other studies. Further attention should be paid to elderly patients who have relatively higher rates of LTBI in developing countries. |
publishDate |
2018 |
dc.date.issued.none.fl_str_mv |
2018 |
dc.date.accessioned.none.fl_str_mv |
2019-05-27T13:09:01Z |
dc.date.available.none.fl_str_mv |
2019-05-27T13:09:01Z |
dc.type.spa.fl_str_mv |
Artículo de revista |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.content.spa.fl_str_mv |
Text |
dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.redcol.spa.fl_str_mv |
http://purl.org/redcol/resource_type/ART |
dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/acceptedVersion |
format |
http://purl.org/coar/resource_type/c_6501 |
status_str |
acceptedVersion |
dc.identifier.uri.spa.fl_str_mv |
https://hdl.handle.net/11323/4707 |
dc.identifier.instname.spa.fl_str_mv |
Corporación Universidad de la Costa |
dc.identifier.reponame.spa.fl_str_mv |
REDICUC - Repositorio CUC |
dc.identifier.repourl.spa.fl_str_mv |
https://repositorio.cuc.edu.co/ |
url |
https://hdl.handle.net/11323/4707 https://repositorio.cuc.edu.co/ |
identifier_str_mv |
Corporación Universidad de la Costa REDICUC - Repositorio CUC |
dc.language.iso.none.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.spa.fl_str_mv |
https://doi.org/10.1016/j.jval.2018.04.827 |
dc.rights.spa.fl_str_mv |
Attribution-NonCommercial-ShareAlike 4.0 International |
dc.rights.uri.spa.fl_str_mv |
http://creativecommons.org/licenses/by-nc-sa/4.0/ |
dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
rights_invalid_str_mv |
Attribution-NonCommercial-ShareAlike 4.0 International http://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2 |
eu_rights_str_mv |
openAccess |
dc.publisher.spa.fl_str_mv |
Value in health 21 |
institution |
Corporación Universidad de la Costa |
bitstream.url.fl_str_mv |
https://repositorio.cuc.edu.co/bitstreams/51c93a45-998e-41be-9088-995f4949f754/download https://repositorio.cuc.edu.co/bitstreams/ac0cc286-d211-403a-97dc-a208d5958c63/download https://repositorio.cuc.edu.co/bitstreams/e8b1bdd0-ec8c-49c9-9227-b45f83f72f4c/download https://repositorio.cuc.edu.co/bitstreams/86bcfbfe-6575-4009-8b9f-903cf5be0f12/download https://repositorio.cuc.edu.co/bitstreams/a7e3708f-45b6-48f2-928f-71971cc2c6ab/download |
bitstream.checksum.fl_str_mv |
b6737d8b68a625bc97226854fc1d7a85 934f4ca17e109e0a05eaeaba504d7ce4 8a4605be74aa9ea9d79846c1fba20a33 8b52ac6ab8efb1cb84fadeeb27604ca5 75f08b6b064381fac5c2d00ee5d8fb8a |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio de la Universidad de la Costa CUC |
repository.mail.fl_str_mv |
repdigital@cuc.edu.co |
_version_ |
1828166867798196224 |
spelling |
Santos-Moreno, PAlvis-Zakzuk, NJCarrasquilla, MVillarreal, LAlvis Guzman, N2019-05-27T13:09:01Z2019-05-27T13:09:01Z2018https://hdl.handle.net/11323/4707Corporación Universidad de la CostaREDICUC - Repositorio CUChttps://repositorio.cuc.edu.co/Objectives: Tuberculosis has an important burden of disease in developing countries. The aim of this study was to estimate the prevalence of latent tuberculosis infection (LTBI) in a cohort of patients with rheumatoid arthritis (RA) in a specialized center of excellence. Method: We conducted a retrospective study to explore the prevalence of LTBI in patients with RA in a single setting located in Bogota, Colombia. Under a Treat to Target model we followed patients diagnosed with RA who received biological and conventional therapy treated in 2017. Patients were tested using tuberculin skin test (TST). Thresholds of this test were defined according to CDC recommendations. We stratified the analysis by sex, type of treatment (conventional and biological therapy) and negative and positive LTBI. Means and standard deviations were reported for continuous variables and categorical variables were presented as percentages. Results: We included 329 patients diagnosed with AR who were tested for LTBI, 60,2% were women. Mean age was 67.1 years (standard deviation 10.4). According to the therapy, 77.2% were treated with biological and 22.8% with conventional therapy. As far as diseases were concerned including RA, some comorbidities were assessed at the beginning of the follow-up, showing that 26.4% (87/329) had hypertension, 6.1% (20/329) diabetes mellitus and 6,4% (21/329) Sjogren syndrome. As main result, the prevalence of LTBI in patients was 8.2% (27/329) (295 patients had a negative TST, 12 had a TST from 10mm to 15, and 15 patients had a TST >15mm). Conclusions: This study is one of the first approach in Colombia to estimate the prevalence of latent tuberculosis infection. Our estimation of LTBI prevalence was similar to the findings in other studies. Further attention should be paid to elderly patients who have relatively higher rates of LTBI in developing countries.Objetivos: La tuberculosis tiene una importante carga de enfermedad en los países en desarrollo. El objetivo de este estudio fue estimar la prevalencia de la infección tuberculosa latente (TBI) en una cohorte de pacientes con artritis reumatoide (AR) en un centro especializado de excelencia. Método: Realizamos un estudio retrospectivo para explorar la prevalencia de TBI en pacientes con AR en un entorno único ubicado en Bogotá, Colombia. Bajo un modelo de Treat to Target, seguimos a los pacientes diagnosticados con AR que recibieron tratamiento biológico y convencional en 2017. Los pacientes fueron evaluados utilizando la prueba cutánea de tuberculina (TST). Los umbrales de esta prueba se definieron de acuerdo con las recomendaciones de los CDC. Se estratificó el análisis por sexo, tipo de tratamiento (convencional y terapia biológica) y LTBI negativo y positivo. Las medias y las desviaciones estándar se informaron para las variables continuas y las variables categóricas se presentaron como porcentajes. Resultados: Se incluyeron 329 pacientes con diagnóstico de AR que se evaluaron para la LBI, el 60,2% eran mujeres. La edad media fue de 67,1 años (desviación estándar 10,4). De acuerdo con la terapia, 77.2% fueron tratados con biológicos y 22.8% con tratamientos convencionales. En cuanto a las enfermedades, incluida la AR, se evaluaron algunas comorbilidades al inicio del seguimiento, lo que muestra que el 26,4% (87/329) tenía hipertensión, el 6,1% (20/329) diabetes mellitus y el 6,4% (21). / 329) Síndrome de Sjogren. Como resultado principal, la prevalencia de LTBI en pacientes fue del 8,2% (27/329) (295 pacientes tuvieron una TST negativa, 12 tuvieron una TST de 10 a 15 y 15 pacientes tuvieron una TST> 15 mm). Conclusiones: este estudio es uno de los primeros enfoques en Colombia para estimar la prevalencia de la infección tuberculosa latente. Nuestra estimación de la prevalencia de LTBI fue similar a los hallazgos en otros estudios. Se debe prestar mayor atención a los pacientes de edad avanzada que tienen tasas relativamente más altas de LTBI en los países en desarrollo.Santos-Moreno, P-4c8bf522-fd2f-4d0d-bd00-433bf39bccbf-0Alvis-Zakzuk, NJ-c00455f6-7d08-4c2a-be77-a48bac8ff64c-0Carrasquilla, M-c777b5bf-3e08-468d-9bb7-9fdd4a8f5e28-0Villarreal, L-0e7db4bd-aaff-42eb-b6c7-f475dbb3fe50-0Alvis Guzman, N-2d13fafb-f99f-45da-90f0-c24f33bc4418-0engValue in health 21https://doi.org/10.1016/j.jval.2018.04.827Attribution-NonCommercial-ShareAlike 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2TuberculosisPaíses en desarrolloPrevalencia de la infección tuberculosa latenteArtritis reumatoideTuberculosisDeveloping countriesPrevalence of latent tuberculosis infectionRheumatoid arthritisPrevalence of latent tuberculosis infection in patients with rheumatoid arthritis in Colombia: a single setting studyPrevalencia de la infección tuberculosa latente en pacientes con artritis reumatoide en Colombia: un estudio único.Artículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/acceptedVersionPublicationORIGINALPrevalence of Latent Tuberculosis Infection in Patients.pdfPrevalence of Latent Tuberculosis Infection in Patients.pdfapplication/pdf57643https://repositorio.cuc.edu.co/bitstreams/51c93a45-998e-41be-9088-995f4949f754/downloadb6737d8b68a625bc97226854fc1d7a85MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81031https://repositorio.cuc.edu.co/bitstreams/ac0cc286-d211-403a-97dc-a208d5958c63/download934f4ca17e109e0a05eaeaba504d7ce4MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.cuc.edu.co/bitstreams/e8b1bdd0-ec8c-49c9-9227-b45f83f72f4c/download8a4605be74aa9ea9d79846c1fba20a33MD53THUMBNAILPrevalence of Latent Tuberculosis Infection in Patients.pdf.jpgPrevalence of Latent Tuberculosis Infection in Patients.pdf.jpgimage/jpeg81317https://repositorio.cuc.edu.co/bitstreams/86bcfbfe-6575-4009-8b9f-903cf5be0f12/download8b52ac6ab8efb1cb84fadeeb27604ca5MD55TEXTPrevalence of Latent Tuberculosis Infection in Patients.pdf.txtPrevalence of Latent Tuberculosis Infection in Patients.pdf.txttext/plain12160https://repositorio.cuc.edu.co/bitstreams/a7e3708f-45b6-48f2-928f-71971cc2c6ab/download75f08b6b064381fac5c2d00ee5d8fb8aMD5611323/4707oai:repositorio.cuc.edu.co:11323/47072024-09-17 14:19:47.921http://creativecommons.org/licenses/by-nc-sa/4.0/Attribution-NonCommercial-ShareAlike 4.0 Internationalopen.accesshttps://repositorio.cuc.edu.coRepositorio de la Universidad de la Costa CUCrepdigital@cuc.edu.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 |